The company’s total revenue also increased 4.1 percent, from $48.5 million in the third quarter of 2012 to $50.4 million. However, 2013’s third quarter net loss came in at $2.6 million, up from 2012’s $1.3 million.
Alphatec has several devices lined up for this year, including the Pegasus anchored, anterior cervical interbody device; Alphatec Solus anterior lumbar interbody fusion device; and ILLICO Multilevel minimally invasive system.
More Articles on Devices:
Integra LifeSciences Launches Hollywood VI Lumbar Fusion Cage
Medtronic Spine Launches Device for Multilevel Spinal Fusion
Wenzel Spine Launches Cervical Interbody Fusion Implant
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
